Core Insights - Teladoc Health, Inc. reported a 2% decrease in revenue for Q3 2025, totaling $626.4 million compared to $640.5 million in Q3 2024, with a net loss of $49.5 million or $0.28 per share [5][6][8] - The company continues to focus on strategic priorities, including growth initiatives in the Integrated Care segment and the rollout of insurance acceptance in BetterHelp [3] Financial Performance - Revenue for Q3 2025 was $626.4 million, down 2% from $640.5 million in Q3 2024; access fees revenue decreased 6% to $520.9 million, while other revenue increased 24% to $105.5 million [5][32] - U.S. revenue decreased 5% to $509.8 million, while international revenue increased 12% to $116.7 million [5][32] - Integrated Care segment revenue increased 2% to $389.5 million, while BetterHelp segment revenue decreased 8% to $236.9 million [5][36] Loss and Adjusted EBITDA - Net loss for Q3 2025 was $49.5 million, compared to a loss of $33.3 million in Q3 2024; adjusted EBITDA decreased 16% to $69.9 million [6][10] - The Integrated Care segment's adjusted EBITDA decreased 3% to $66.1 million, while BetterHelp's adjusted EBITDA decreased 75% to $3.8 million [10][36] Nine-Month Performance - For the first nine months of 2025, revenue decreased 2% to $1.887 billion from $1.929 billion in the same period of 2024 [11] - Net loss for the first nine months of 2025 was $175.2 million, significantly improved from a loss of $952.8 million in the same period of 2024 [12] Cash Flow and Capital Expenditures - Cash flow from operations was $99.3 million in Q3 2025, down from $110.2 million in Q3 2024; free cash flow was $67.9 million compared to $79.0 million in Q3 2024 [16] - Capital expenditures for Q3 2025 were $31.3 million, slightly up from $31.1 million in Q3 2024 [16] Financial Outlook - For the full year 2025, the company expects revenue between $2.510 billion and $2.539 billion, with adjusted EBITDA between $270 million and $287 million [19][20] - The fourth quarter of 2025 is projected to have revenue between $622 million and $652 million, with adjusted EBITDA between $73 million and $90 million [21]

Core Insights - Teladoc Health reported a consolidated revenue of $631.9 million for the second quarter of 2025, a decrease of 2% compared to $642.4 million in the same period of 2024 [5][6] - The company achieved a net loss of $32.7 million, or $0.19 per share, significantly improved from a net loss of $837.7 million, or $4.92 per share, in the second quarter of 2024 [7][12] - Adjusted EBITDA for the second quarter of 2025 was $69.3 million, down 23% year-over-year from $89.5 million [10][15] Financial Performance - Revenue breakdown: Access fees revenue decreased by 6% to $523.7 million, while other revenue increased by 31% to $108.2 million [6][33] - U.S. revenue decreased by 4% to $519.7 million, while international revenue increased by 10% to $112.2 million [6][11] - Integrated Care segment revenue increased by 4% to $391.5 million, while BetterHelp segment revenue decreased by 9% to $240.4 million [6][35] Cost and Expenses - Total costs and expenses for the second quarter of 2025 were $686.3 million, compared to $1.5 billion in the second quarter of 2024, which included a significant goodwill impairment charge [30][9] - Stock-based compensation expense was $22.3 million for the second quarter of 2025, down from $42.1 million in the same quarter of 2024 [32][9] Cash Flow and Capital Expenditures - Cash flow from operations was $91.4 million in the second quarter of 2025, compared to $88.7 million in the second quarter of 2024 [16] - Capital expenditures were $30.2 million in the second quarter of 2025, up from $27.7 million in the same period of 2024 [16] Financial Outlook - For the full year of 2025, the company expects revenue between $2.501 billion and $2.548 billion, with adjusted EBITDA projected between $263 million and $294 million [20][21] - The third quarter of 2025 outlook includes expected revenue of $614 million to $636 million and adjusted EBITDA of $56 million to $70 million [22] Strategic Initiatives - The CEO emphasized the importance of virtual care as a performance multiplier in addressing challenges in the healthcare landscape [4] - The company is focused on enhancing patient experience, improving clinical outcomes, and driving greater value for clients [4]